Immune cell profiling in Gleason 9 prostate cancer patients treated with brachytherapy versus external beam radiotherapy: an exploratory study

This exploratory study evaluates immunological changes in high-risk Gleason 9 prostate cancer patients treated with EBRT+BT compared to EBRT alone. Notably, BT demonstrates the potential to elicit a T cell response which may support further investigation using circulating immune cells as predictive and prognostic biomarkers for radiotherapy response.

Source: Radiotherapy and Oncology - October 23, 2020 Category: Radiology Authors: H Wang, L Mendez, G Morton, A Loblaw, A Mesci, H Chung, S Chan, X Huang, M Downes, D Vesprini, SK Liu Tags: Short Communication Source Type: research